http://www.edrugsearch.com/edsblog/fda-cant-keep-up-with-big-pharma-advertising-claims/ Helping Americans Buy Prescription Drugs Online from Canada Wed, 01 Feb 2012 00:09:42 +0000 hourly 1 http://wordpress.org/?v=3.3.1 http://www.edrugsearch.com/edsblog/fda-cant-keep-up-with-big-pharma-advertising-claims/comment-page-1/#comment-32142 eDrugSearch Blog » Blog Archive » When it comes to drug ads, is the FDA the new MPAA? Mon, 23 Apr 2007 06:35:08 +0000 http://edrugsearch.com/edsblog/fda-cant-keep-up-with-big-pharma-advertising-claims/#comment-32142 [...] The FDA positions the plan as a toughening of previously lax regulations in response to public complaints about direct-to-consumer ads. The reality is, the projected $6 million in annual fees for FDA review would primarily serve to keep the drug ads coming at a blistering pace. As one observer sums up FDA priorities: [FDA officials] behave as if their job is to get as many “good products” to the American public as quickly as they can. The focus should be on public safety rather than on facilitation of the drug availability process. [...] [...] The FDA positions the plan as a toughening of previously lax regulations in response to public complaints about direct-to-consumer ads. The reality is, the projected $6 million in annual fees for FDA review would primarily serve to keep the drug ads coming at a blistering pace. As one observer sums up FDA priorities: [FDA officials] behave as if their job is to get as many “good products” to the American public as quickly as they can. The focus should be on public safety rather than on facilitation of the drug availability process. [...]

]]>